28 Feb 2024 --- Kerry Group’s subsidiary c-LEcta and German coffee tech firm Anka have formulated a new food enzyme to reduce acrylamide in instant coffee and ready to drink coffee beverages. The enzyme Acrylerase is hailed as the “first to target acrylamide directly” and is expected to help coffee manufacturers with on-site control of the potential carcinogen.
